EUVIMEDEUVIMED entdecken
Crossref

Administration of intravenous iron through a home‐based infusion strategy is safe and has high patient acceptance

Dorothy Liu iD, Eloisa Atienza, Lynne Santamaria, Rabin Sinnappu, Mayur Garg

Internal Medicine Journal · 2024

DOI: 10.1111/imj.16075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Internal Medicine Journal, 2024. Verfasst von Dorothy Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Northern Health, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Iron, Anemia, Iron-Deficiency, Disaccharides, Ferric Compounds. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims To evaluate the safety and patient experience of a hospital‐initiated home‐based iron infusion service in patients with iron deficiency with or without anaemia.

Methods

Retrospective cohort study, including adult patients who received intravenous iron through a Hospital in The Home service in a single tertiary centre between August 2020 and 2021. A chart review was conducted for documented adverse events (AEs). A telephone survey assessed patient acceptance with three questions on a 5‐point Likert scale: (i) How do you perceive the experience of having your infusion given in the home? (ii) Would you like to have the infusion in the same location if you require one in the future? and (iii) Do you feel safe having your infusion at home? Outcome measures Percentage of patients experiencing AEs and patient acceptance of a home‐based iron infusion strategy.

Results

One hundred ninety‐seven patients were included (181 ferric carboxymaltose and 16 ferric derisomaltose). Six (3%) patients (2 of 181 patients who received ferric carboxymaltose compared with 4 of 16 patients who received ferric derisomaltose, P < 0.001, Fisher's exact) experienced AEs, mostly headache and pruritus. Most patients who participated in the telephone survey had a positive experience (57/58 (98%)), felt safe (57/58 (98%)) and preferred future infusions to occur at home (52/58 (90%)).

Conclusion

A home‐based iron infusion strategy was safe and well accepted by patients. Larger studies evaluating the safety profile of different iron formulations in the home setting are required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IronAnemia, Iron-DeficiencyDisaccharidesFerric CompoundsAdultHumansRetrospective StudiesAdministration, IntravenousInfusions, IntravenousMaltose

Stichwörter der Autor:innen

ferric carboxymaltoseferric derisomaltoseiron deficiencyiron deficiency anaemiairon infusion

Substanzen

Ironferric derisomaltoseferric carboxymaltoseDisaccharidesFerric CompoundsMaltose

Autor:innen und Institutionen

  • Department of Gastroenterology, Northern Health, Melbourne, Victoria, Australia.
  • Hospital in the Home Service, Northern Health, Melbourne, Victoria, Australia.
  • Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.

ORCID-Profile: Dorothy Liu

Zitieren

APA

Liu, D., Atienza, E., Santamaria, L., Sinnappu, R., & Garg, M. (2024). Administration of intravenous iron through a home‐based infusion strategy is safe and has high patient acceptance. Internal Medicine Journal. https://doi.org/10.1111/imj.16075

Vancouver

Liu D, Atienza E, Santamaria L, Sinnappu R, Garg M. Administration of intravenous iron through a home‐based infusion strategy is safe and has high patient acceptance. Internal Medicine Journal. 2024. doi:10.1111/imj.16075

BibTeX
@article{Liu2024,
  author = {Liu, Dorothy and Atienza, Eloisa and Santamaria, Lynne and Sinnappu, Rabin and Garg, Mayur},
  title = {Administration of intravenous iron through a home‐based infusion strategy is safe and has high patient acceptance},
  journal = {Internal Medicine Journal},
  year = {2024},
  doi = {10.1111/imj.16075}
}
Kostenlos starten →